Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Alginor Pharma Ingredients AS
AS
Active
Org 928521672
Husøyvegen 260, 4262
Avaldsnes
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 4 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Manufacture of pharmaceutical preparations
/
Alginor Pharma Ingredients AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
Revenue
0
0
400
0
Staff expenses
−0
−0
−0
−0
EBITDA
−317
−55
−89
0
Depreciation & amort.
−0
−0
−0
−0
EBIT
−317
−55
−89
0
Net financials
89
148
0
0
Profit before tax
−228
93
−89
0
Tax
−0
1
−0
−0
Net profit
−228
92
−89
0
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
Total assets
33 038
18 765
10 395
100
Equity
9 772
10 000
9 911
100
Long-term debt
0
0
0
0
Short-term debt
23 266
8 765
484
0
Total debt
23 266
8 765
484
0
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2024
Equity ratio
29,6 %
This company
38,2 %
Market median
This company
Market median
23% below market
2021
2024
Return on equity
−2,3 %
This company
18,4 %
Market median
This company
Market median
113% below market
2021
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2024
Debt / equity
2,38×
This company
0,62×
Market median
This company
Market median
284% above market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Alginor Pharma Ingredients AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
